About the Authors

Audrey Rouault

Affiliation French National Institute of Health and Medical Research (INSERM) Unit 916, University of Bordeaux, Bergonié Cancer Institute, Bordeaux, France

Guillaume Banneau

Affiliation French National Institute of Health and Medical Research (INSERM) Unit 916, University of Bordeaux, Bergonié Cancer Institute, Bordeaux, France

Gaëtan MacGrogan

Affiliations French National Institute of Health and Medical Research (INSERM) Unit 916, University of Bordeaux, Bergonié Cancer Institute, Bordeaux, France, Pathology Department, Bergonié Cancer Institute, Bordeaux, France

Natalie Jones

Affiliation French National Institute of Health and Medical Research (INSERM) Unit 916, University of Bordeaux, Bergonié Cancer Institute, Bordeaux, France

Nabila Elarouci

Affiliation Cartes d’Identité des Tumeurs (CIT) Program, Ligue Nationale Contre Le Cancer, Paris, France

Emmanuelle Barouk-Simonet

Affiliation Cancer Genetics Unit, Bergonié Cancer Institute, Bordeaux, France

Laurence Venat

Affiliation Department of Medical Oncology, Dupuytren University Hospital, Limoges, France

Isabelle Coupier

Affiliation Cancer Genetics Unit, Val d’Aurelle Regional Cancer Centre, Montpellier, France

Eric Letouzé

Affiliation Cartes d’Identité des Tumeurs (CIT) Program, Ligue Nationale Contre Le Cancer, Paris, France

Aurélien de Reyniès

Affiliation Cartes d’Identité des Tumeurs (CIT) Program, Ligue Nationale Contre Le Cancer, Paris, France

Françoise Bonnet

Affiliations French National Institute of Health and Medical Research (INSERM) Unit 916, University of Bordeaux, Bergonié Cancer Institute, Bordeaux, France, Cancer Genetics Unit, Bergonié Cancer Institute, Bordeaux, France

Richard Iggo

r.iggo@bordeaux.unicancer.fr

Affiliation French National Institute of Health and Medical Research (INSERM) Unit 916, University of Bordeaux, Bergonié Cancer Institute, Bordeaux, France

Nicolas Sévenet

Affiliations French National Institute of Health and Medical Research (INSERM) Unit 916, University of Bordeaux, Bergonié Cancer Institute, Bordeaux, France, Cancer Genetics Unit, Bergonié Cancer Institute, Bordeaux, France

Michel Longy

Affiliations French National Institute of Health and Medical Research (INSERM) Unit 916, University of Bordeaux, Bergonié Cancer Institute, Bordeaux, France, Cancer Genetics Unit, Bergonié Cancer Institute, Bordeaux, France

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: ML RI NS. Performed the experiments: AR GB. Analyzed the data: GM RI AR EL AdR NE. Contributed reagents/materials/analysis tools: EBS ML LV IC. Wrote the paper: RI ML AR. Performed mutation screening: NJ FB NS.